Marshall Wace, LLP Dyadic International Inc Transaction History

Marshall Wace, LLP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 13, 2021	SELL	$3.35 - $5.67 $105,829 - $179,120	-31,591 Reduced 8.93%	322,075 $1.16 Million
Q1 2021 May 17, 2021	BUY	$4.75 - $6.87 $1.68 Million - $2.43 Million	353,666 New	353,666 $1.94 Million
Q1 2020 May 15, 2020	SELL	$2.58 - $6.6 $47,074 - $120,423	-18,246 Closed	0 $0
Q4 2019 Feb 14, 2020	SELL	$5.02 - $6.66 $25,858 - $34,305	-5,151 Reduced 22.02%	18,246 $95,000
Q3 2019 Nov 14, 2019	BUY	$4.98 - $6.7 $116,517 - $156,759	23,397 New	23,397 $143,000

4.77M

20.6K

Ticker DYAI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 28,423,100
Market Cap $51.7M
Description
Dyadic International, Inc., a biotechnology platform company, develops, produces, and sells enzymes and other proteins in the United States. The company utilizes its patented and proprietary C1 platform and other technologies to conduct research, development, and commercial activities for the development and manufacturing of human and animal vac...

Get notified when there are updates to the investment portfolio of Marshall Wace, LLP, based on Form 13F filings with the SEC.

Stay updated on Marshall Wace, LLP with notifications on news.